Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | GFER | P55789 | 1/20 | 0.43 |
| ▸ | CNR2 | P34972 | 2/20 | 0.39 |
| ▸ | RARB | P10826 | 4/20 | 0.37 |
| ▸ | RARA | P10276 | 3/20 | 0.37 |
| ▸ | RARG | P13631 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27199176 | 0.91 | SELL (0.45) | MEN1KMT2APOLBGAAGFER | |
| SCHEMBL15771427 | 0.89 | MEN1 (0.39) | MEN1KMT2APOLBGAAGFER | |
| SCHEMBL3764420 | 0.88 | MEN1 (0.38) | MEN1KMT2APOLBGAAGFER | |
| SCHEMBL549486 | 0.86 | MEN1 (0.44) | MEN1KMT2APOLBGAAGFER | |
| SCHEMBL15454103 | 0.85 | RARB (0.40) | MEN1KMT2APOLBGAAGFER | |
| SCHEMBL11297995 | 0.84 | ALOX12 (0.37) | MEN1KMT2APOLBGAAGFER | |
| SCHEMBL15531154 | 0.84 | ALOX12 (0.37) | MEN1KMT2APOLBGAAGFER | |
| SCHEMBL15613285 | 0.84 | ALOX12 (0.37) | MEN1KMT2APOLBGAAGFER | |
| SCHEMBL1685213 | 0.84 | ERN1 (0.53) | MEN1KMT2APOLBGAAGFER | |
| SCHEMBL27959897 | 0.84 | ALOX12 (0.37) | MEN1KMT2APOLBGAAGFER |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3052229-B1 | IMMOBILIZED METATHESIS TUNGSTEN OXO ALKYLIDENE CATALYSTS AND USE THEREOF IN OLEFIN METATHESIS | VERBIO VER BIOENERGIE AG (DE) | 2021-02-24 | — | — | EP | disclosed |
| US-10427146-B2 | Immobilized metathesis tungsten oxo alkylidene catalysts and use thereof in olefin metathesis | XIMO AG (CH) | 2019-10-01 | — | — | US | disclosed |
| US-20160236185-A1 | IMMOBILIZED METATHESIS TUNGSTEN OXO ALKYLIDENE CATALYSTS AND USE THEREOF IN OLEFIN METATHESIS | VERBIO SE (DE) | 2016-08-18 | — | — | US | disclosed |
| EP-3052229-A1 | IMMOBILIZED METATHESIS TUNGSTEN OXO ALKYLIDENE CATALYSTS AND USE THEREOF IN OLEFIN METATHESIS | XiMo AG (CH) | 2016-08-10 | — | — | EP | disclosed |
| US-8110614-B2 | Adamantane derivative, method for producing the same, and resin composition containing adamantane derivative | IDEMITSU KOSAN CO., LTD. (JP) | 2012-02-07 | — | — | US | disclosed |
| US-20100056663-A1 | ADAMANTANE DERIVATIVE, METHOD FOR PRODUCING THE SAME, AND RESIN COMPOSITION CONTAINING ADAMANTANE DERIVATIVE | IDEMITSU KOSAN CO., LTD. (JP) | 2010-03-04 | — | — | US | disclosed |
| EP-2090563-A1 | ADAMANTANE DERIVATIVE, METHOD FOR PRODUCING THE SAME, AND RESIN COMPOSITION CONTAINING ADAMANTANE DERIVATIVE | IDEMITSU KOSAN COMPANY LIMITED (JP) | 2009-08-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10427146-B2 | Immobilized metathesis tungsten oxo alkylidene catalysts and use thereof in olefin metathesis | CCR2, SIK2, CCRL2 | MEN1 2643/4885KMT2A 839/4885POLB 2229/4885 |
| US-20160236185-A1 | IMMOBILIZED METATHESIS TUNGSTEN OXO ALKYLIDENE CATALYSTS AND USE THEREOF IN OLEFIN METATHESIS | SIK2, CCR2, CCRL2 | MEN1 2652/4885KMT2A 840/4885POLB 2081/4885 |
| US-20100056663-A1 | ADAMANTANE DERIVATIVE, METHOD FOR PRODUCING THE SAME, AND RESIN COMPOSITION CONTAINING ADAMANTANE DERIVATIVE | ARCN1, RTN3, CHRNA3 | MEN1 3412/4885KMT2A 3737/4885POLB 3648/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.